Sources of Interindividual Variability in IVIVE of Clearance: An Investigation into the Prediction of Benzodiazepine Clearance Using a Mechanistic Population-based Pharmacokinetic Model Publication Sources of Interindividual Variability in IVIVE of Clearance: An Investigation into the Prediction of Benzodiazepine Clearance Using a Mechanistic Population-based Pharmacokinetic Model Prediction of metabolic clearance in extreme individuals rather than the 'average human' is becoming an…CertaraMarch 24, 2011
Is a Monte Carlo Simulation an Exotic Drink? Knowledge Base Is a Monte Carlo Simulation an Exotic Drink? The term “Monte Carlo simulation” is often used in the modeling and simulation literature with…CertaraMarch 21, 2011
What is WinNonlin? Knowledge Base What is WinNonlin? A reader suggested that I write a similar post about WinNonlin. Great idea! Thank you!…CertaraMarch 16, 2011
What is the Difference Between Individual and Population PK? Knowledge Base What is the Difference Between Individual and Population PK? Pharmacokinetic analysis is often broken into two areas … “PK” and “population PK”. Sometimes the…CertaraMarch 14, 2011
Utility of Intersystem Extrapolation Factors in Early Reaction Phenotyping and the Quantitative Extrapolation of Human Liver Microsomal Intrinsic Clearance Using Recombinant Cytochromes P450 Publication Utility of Intersystem Extrapolation Factors in Early Reaction Phenotyping and the Quantitative Extrapolation of Human Liver Microsomal Intrinsic Clearance Using Recombinant Cytochromes P450 Reaction phenotyping using recombinant human cytochromes P450 (P450) has great utility in early discovery. However,…CertaraMarch 1, 2011
Casopitant: In Vitro Data and Simcyp Simulation to Predict In Vivo Metabolic Interactions Involving Cytochrome P450 3A4 Publication Casopitant: In Vitro Data and Simcyp Simulation to Predict In Vivo Metabolic Interactions Involving Cytochrome P450 3A4 has previously been shown to be a potent and selective antagonist of the human neurokinin-1…CertaraMarch 1, 2011
Modeling and Predicting Drug Pharmacokinetics in Patients with Renal Impairment Publication Modeling and Predicting Drug Pharmacokinetics in Patients with Renal Impairment Current guidance issued by the US FDA to assess the impact of renal impairment on…CertaraMarch 1, 2011
Resurgence in the Use of Physiologically-based Pharmacokinetic Models in Pediatric Clinical Pharmacology: Parallel Shift in Incorporating the Knowledge of Biological Elements and Increased Applicability to Drug Development and Clinical Practice Publication Resurgence in the Use of Physiologically-based Pharmacokinetic Models in Pediatric Clinical Pharmacology: Parallel Shift in Incorporating the Knowledge of Biological Elements and Increased Applicability to Drug Development and Clinical Practice This study had two primary aims: (i) To describe an example of the development work…CertaraMarch 1, 2011
Blood or Plasma? Which Should You Assay for Drug Concentration? Knowledge Base Blood or Plasma? Which Should You Assay for Drug Concentration? Explore blood vs. plasma drug concentration assays. Learn their differences, relationships, and impact on accurate…CertaraFebruary 19, 2011
Why Should You Evaluate Dose Proportionality? BlogKnowledge Base Why Should You Evaluate Dose Proportionality? Dose proportionality is a common phrase used pharmacokinetics. Early in the pre-clinical development process, we…CertaraFebruary 17, 2011